BRIEFCASE | SEARCH | LOGIN    
RSNA 2004 > Contrast-enhanced MR Imaging of the Heart in Patients ...
 
Scientific Papers
  CODE: SST08-04
  SESSION: Cardiac (MR Imaging: General Cardiac Diagnosis)
  Contrast-enhanced MR Imaging of the Heart in Patients with End-Stage Renal Disease

TOOLS
 
Add to Briefcase
  Print
  Email Event
PARTICIPANTS
Presenter
Ulrich Kramer MD
Abstract Co-Author
Sabine Wolf
Michael Fenchel MD
Alessandra Kraft
Claus Claussen MD
Stephan Miller MD
- Author stated no financial disclosure

- Disclosure information unavailable
  DATE: Friday, December 03 2004
  START TIME: 11:00 AM
  END TIME: 11:10 AM
  LOCATION: E353C

 PURPOSE
 
Cardiac disease has a high incidence in patients undergoing long term hemodialysis. The survival rate is influenced by myocardial function, left ventricular (LV) ejection fraction (EF), severity of LV dilatation and hypertrophy which can be accurately determined by MR imaging. Autopsy studies revealed that myocardial fibrosis is an additional factor for LV functional impairment. This study investigates Gd-DTPA contrast enhanced MR imaging in correlation to myocardial morphology and function to detect fibrotic myocardial changes in patients with end-stage renal disease (ESRD).
  
 METHOD AND MATERIALS
 
Ten healthy volunteers and 25 patients with ESRD were examined at 1.5T (Magnetom Sonata, Siemens) including cine trueFISP 2D and contrast enhanced inversion-recovery prepared segmented turboFLASH sequences (0.15 mmol Gd-DTPA/kg). Based on a 16 segment model of the LV and 6 segment model of the RV an individual score was determined by segmentally rating myocardial contrast enhancement from 0 (=normal) to 3 (=markedly elevated) for each study subject. Contrast to noise (CNR) was measured in reference regions of interest and regions with visually detectable enhancement. EF, LV mass and end-diastolic volumes (EDV) were calculated based on the modified Simpson rule.
  
 RESULTS
 
Patchy, stripe like or focal endocardial contrast enhancement of the LV was present in 22/25 and of the RV in 10/25 patients (volunteers 6/10 and 2/10). The following parameters were found in patients/ volunteers: EDV 146±47ml/117±38ml (p<0.001), LV mass 144±46g/92±31g (p<0.001), mean rating of segmental enhancement 0.84±0.98/0.30±0.47 (p<0.001), mean score 13.08±8.53 (range 0-31)/4.60±3.58 (range 0-9, p<0.001), CNR 3.08±2.77/1.2±0.8 (p<0.001). Close correlation was found comparing EF and CNR (r=0.75, p<0.0001). Intermediate correlation was observed for enhancement score and EF (r=0.52, p<0.008).
  
 CONCLUSIONS
 
Increased CNR and different types of focal contrast enhancement can be detected in patients with ESRD. We suppose that these findings are consistent with focal and/ or diffuse myocardial fibrosis. Close correlation of CNR and EF suggests that the diffuse type is more relevant for cardiac functional impairment than the focal pattern.
  
Copyright © 2004 Radiological Society of North America, Inc.
820 Jorie Boulevard, Oak Brook, IL 60523-2251 || (630) 571-2670 || fax (630) 571-7837
U.S. and Canada: Main (800) 381-6660, Membership (877) RSNA-MEM (776-2636)
.13